About a PSMA PET Scan

If you have prostate cancer or are concerned about it, you may want to consider having a PSMA PET scan. This type of PET scan uses a safe, radioactive tracer to find cancer cells and show them in your body on an image. It can also help uro-oncologists determine whether or not cancer has spread.

For this imaging test, doctors inject a radiotracer into your body via an intravenous line. The tracer is attracted to the protein found on prostate cancer cells called PSMA (prostate-specific membrane antigen). It then lights up during the PET scan. The uro-oncologist will be able to see the areas that light up and make a diagnosis.

During the PET scan, you will have to wait for an hour or two. You will be asked to drink 32-64 ounces of water to help with the procedure. This is because the radiotracer will be absorbed by your body and pass through your bloodstream to the prostate. Then, it will leave your body through your urine. Because of this, you might feel a bit radioactive for a few hours after the scan.

PSMA PET scans are more accurate than other imaging techniques, such as CT or MRI, for detecting metastatic prostate cancer. This makes them a good choice for men who have recently been diagnosed with prostate cancer, or whose previous treatment has failed and their PSA levels are rising again. Psma Pet Scan In Bangalore can help uro-oncologists better determine the best treatment for each individual patient.

What You Should Know About a PSMA PET Scan

A whole-body 68Ga-PSMA PET/CT scan can be used to identify and locate prostate cancer anywhere in the body, including distant metastasis. The radiotracer in this scan is bound to PSMA receptors, which are located on all prostate gland cells but are elevated in prostate cancer cells. The resulting images can then be analyzed to identify tumors and determine their underlying biology.

This scan is also used to assess how well the previous prostate cancer treatment – like surgery, radiation, or hormone therapy – is working in your case. It can also be used to help guide prostate-directed therapies such as high intensity focussed ultrasound (HIFU) or robotic prostatectomy.

In addition to identifying prostate cancer, this test can help doctors assess how well a patient is responding to treatment and predict the likelihood of cancer recurrence. Because of this, it is a valuable tool for planning future treatments, especially for those patients who are undergoing or considering a radical prostatectomy or other advanced prostate cancer therapy. This can give them peace of mind and more time to plan their next steps.